The University of Chicago Header Logo

Emerging role of the histone deacetylase inhibitor romidepsin in hematologic malignancies.

Emerging role of the histone deacetylase inhibitor romidepsin in hematologic malignancies. Expert Opin Pharmacother. 2010 Dec; 11(18):3073-84.

View in: PubMed